Is Hip Arthroscopy Cost-effective for Femoroacetabular Impingement?
- 1 April 2012
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Orthopaedics and Related Research
- Vol. 470 (4), 1079-1089
- https://doi.org/10.1007/s11999-011-2023-7
Abstract
The impact of hip arthroscopy on health-related quality of life (HRQoL) among younger patients with symptomatic femoroacetabular impingement (FAI) is unknown, but with increasing recognition of the condition there is likely to be increasing demand for arthroscopy. We describe an approach to determine the incremental cost-effectiveness of hip arthroscopy compared with observation in patients with FAI; we also identified variables that influence its cost-effectiveness. We constructed a Markov model including possible health states for 36-year-old patients with FAI using decision analysis software and compared two strategies: (1) observation and (2) hip arthroscopy, followed by THA with disease progression. We estimated the ratio of the incremental cost to the incremental benefit (reflected by HRQoL) of both strategies. We identified studies reporting Harris hip scores and complications after arthroscopy to estimate health state preferences and their probabilities. We performed sensitivity analyses on 30 input variables over a plausible range of estimates to determine the influence of uncertainty on the ICER with particular emphasis on the magnitude and duration of benefit. Among patients with FAI but no radiographic evidence of arthritis, the estimated ICER of hip arthroscopy was $21,700/QALY while the ICER for patients with preoperative arthritis was $79,500/QALY. Alteration of the natural history of arthritis by hip arthroscopy improved the ICER to $19,200/QALY and resulted in cost savings if THA was not performed until at least 16 years after arthroscopy. Although limited by available data, our model suggests hip arthroscopy in patients with FAI without arthritis may result in a favorable ICER compared with other health interventions considered cost-effective. Further studies of hip arthroscopy are needed to determine the impact on quality of life, duration of symptomatic relief, and the effect on the need for subsequent THA.Keywords
This publication has 37 references indexed in Scilit:
- Arthroscopic femoral osteochondroplasty for cam lesions with isolated acetabular chondral damageThe Journal of Bone and Joint Surgery. British volume, 2010
- Prospective Analysis of Hip Arthroscopy with 10-year FollowupClinical Orthopaedics and Related Research, 2010
- Arthroscopic Labral Repair and Treatment of Femoroacetabular Impingement in Professional Hockey PlayersThe American Journal of Sports Medicine, 2009
- Arthroscopic Femoroplasty in the Management of Cam-type Femoroacetabular ImpingementClinical Orthopaedics and Related Research, 2009
- Complications of Arthroscopic Femoroacetabular Impingement Treatment: A ReviewClinical Orthopaedics and Related Research, 2009
- Outcomes following hip arthroscopy for femoroacetabular impingement with associated chondrolabral dysfunctionThe Journal of Bone and Joint Surgery. British volume, 2009
- Early outcome of hip arthroscopy for femoroacetabular impingementThe Journal of Bone and Joint Surgery. British volume, 2008
- Arthroscopic Management of Labral Tears in the HipClinical Orthopaedics and Related Research, 2007
- Correlation of Short Form-36 and Disability Status with Outcomes of Arthroscopic Acetabular Labral DebridementThe American Journal of Sports Medicine, 2005
- Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and MedicineJAMA, 1996